Aging doesn't happen in a straight line. Recent data suggests it’s actually punctuated by discrete transition points around ages 44 and 60. While longevity genetics has started mapping complex epistatic networks—like the GHSR-MRE11A and TERC-SH2B3 interactions—most researchers still treat these SNP-SNP networks as static blueprints. That’s likely a mistake.

The Hypothesis

I propose that the longevity epistatic landscape undergoes a topological phase transition at age 60, shifting from a regime of Intra-Pathway Buffering to Inter-Pathway Compensation. This shift is physically driven by the collapse of 3D genome architecture, specifically the loss of heterochromatin-lamina interactions and the formation of nuclear invaginations.

Mechanistic Reasoning

Existing data identifies 33 intra-pathway and 40 inter-pathway synergies linked to longevity, but these interactions aren't all active at once:

1. Pre-60 Homeostasis (Intra-Pathway): Epistasis is dominated by high-fidelity hubs like TP53-ERCC2. These interactions maintain stability through redundancy within specific pathways, such as DNA repair or IIS. During this stage, inter-pathway synergies remain latent.
2. The 60-Year Tipping Point: As spatial genome architecture degrades, nuclear invaginations sequester or displace loci that were previously close together. This "spatial silencing" destroys the intra-pathway buffering that characterizes the first six decades of life.
3. Post-60 Rescue (Inter-Pathway): To survive past 60, the organism must rely on emergent inter-pathway synergies where SNPs from disparate pathways compensate for the loss of local integrity. The HR=0.665 observed in the TERC-SH2B3 pair is likely a "rescue" effect that only becomes statistically visible—and biologically necessary—after this age-60 reorganization.

Testing the Hypothesis

We can test this using age-stratified Multifactor Dimensionality Reduction (MDR) in large cohorts like the UK Biobank or Biobank Japan.

• Prediction 1: Intra-pathway SNP interactions should show significantly higher mutual information scores in cohorts aged 40–55 than in those aged 75+.
• Prediction 2: Survival associations for inter-pathway pairs like GHSR-MRE11A will reach significance ($p < 0.05$) only in post-60 cohorts, remaining negligible in mid-life groups.
• Falsifiability: If interaction strength (Odds Ratios) for the 40 known inter-pathway synergies stays constant across age 40, 60, and 80 strata, the "Topological Switch" hypothesis is wrong.

Addressing the "Statistical Mirage"

Critics often argue that age-stratification just worsens the multiple-testing burden in epistasis research. However, if the underlying biological architecture is non-linear, pooling data across the 44/60-year boundaries is exactly what creates the "mirage." We aren't finding these interactions because we’re averaging two different network topologies into a single, meaningless mean. By aligning our statistical windows with these biological phase transitions, we might finally see the patterns that linear models ignore.